from ihub re 13d Snippet 1 from Cytodyn Shareholder

New Post Public Reply Private Reply Replies (1) Message Board
crazyjogger925
896
from ihub re 13d


Snippet 1 from Cytodyn Shareholder Community Group on FB:

DATE: JULY 28, 2021
TO: THE PAUL ROSENBAUM GROUP
(Name of Registrant as Specified in Its Charter)
PAUL A. ROSENBAUM
JEFFREY P. BEATY
ARTHUR L. WILMES
THOMAS J. ERRICO, M.D.
BRUCE PATTERSON, M.D.
PETER STAATS, M.D., MBA
MELISSA YEAGER
CCTV PROXY GROUP, LLC
FROM: CONCERNED SHAREHOLDERS
SUBJECT: POTENTIAL FAILURE TO DISCLOSE MATERIAL INFORMATION
The Schedule 13D must be filed within 10 days after the acquisition and must include certain key information, including the purpose of the acquisition. Specifically, Item 4 of Schedule 13D requires the filer to describe any proposals which relate to, among other things, (a) an extraordinary corporate transaction involving the issuer, such as a merger, (b) a sale of a material amount of assets of the issuer, (c) any change to the board of directors of the issuer and (d) any other material change to the issuer’s business or corporate structure.
Shareholders are concerned that the filings to date (13D, 14A) submitted by The Paul Rosenbaum Group (GROUP) to the SEC may contain numerous omissions and, therefore, present material misrepresentations of facts based on prior discussions, communications and commitments made to shareholders and others. NOTE: WE DO NOT KNOW OF, NOR ARE WE MAKING ANY ASSUMPTIONS OF, ANY WRONGDOING OR IMPROPER ACTIONS OR INACTIONS OF THE GROUP. WE SIMPLY WANT TO UNDERSTAND THE GROUP’S PLAN SO THAT SHAREHOLDERDS CAN BE INFORMED.
Please see the following References:
(1) Numerous emails and phone conversations with select shareholders occurring between March 1, 2021 – June 30, 2021.
(2) The Zoom conference call presentation and discussion by Paul Rosenbaum, Bruce Patterson, and others to discuss their plan for taking over the company. This Zoom meeting was held on May 6, 2021.
(3) Zoom Follow Up email from Paul Rosenbaum dated May 6, 2021:
Forwarded message
From: Paul R
Date: Thu, May 6, 2021 at 8:52 PM
Subject: Please make checks payable to CCTV ( Cytodyn Committee to Victory) for $7500
To:
To All:
Thanks for today. I think it was a productive meeting.
As I mentioned before, the checks will not be deposited in an account until we reach our stated goals both for funds needed, and shares required.
I must receive the checks immediately in order to meet our filing requirements
Please call if you have any additional questions
Thanking you in advance for your cooperation
Paul R
Make checks payable to CCTV for $7500.
Paul Rosenbaum
2945 NW Luray Terrace
Portland Oregon 97210
(4) Paul Rosenbaum’s letter of Concern to CytoDyn’s Board of Directors, specifically Section BASIS FOR SHAREHOLDER CONCERN, paragraph 3, which reads as follows:
3. Dismissal of Highly Credible Clinical Partners. There is no doubt that the research and public presentations by IncellDx and Bruce Patterson, MD, have raised CYDY’s public profile and increased its credibility. The circumstances surrounding the breakdown of the relationship between CYDY and IncellDx remain murky, but the results of the breakdown are apparent. IncellDx was a material source of scientific direction and Mechanism of Action (MOA) definition for CYDY. The elimination of this relationship appears to have resulted in a reduced understanding of how Leronlimab works and where drug development research should be focused.
(5) Letter to Dr. Pourhassan from Paul Rosenbaum and other shareholders representing over 175MM shares of stock. See Attachment #1: Letter to Dr. Pourhassan for the complete contents of the letter.
Excerpts:
…we are writing you on behalf of CytoDyn shareholders representing over 175MM shares of common stock and growing.
…The signatures below represent only a portion of the commitment to this position.
…Please do not underestimate our dedication to what is in the best interest of the shareholders.
…An IncellDx investor informed us that IncellDx was NOT involved in the combination therapy trial, and only became involved in the later stages of the mono-therapy trial.
…IncellDx has been leading the way in long hauler research and treatment. We have third party opinions that the IncellDx quantitative CCR5 IHC assay with a scoring system that can be followed, is far superior to what is available on the market today for CCR5 IHC.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NextPatient’s KLAS Marks Signal Specialty Workflow Fit

Updated Category News Views 22

A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 157

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 127

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 64

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 130

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 24

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 194

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 0

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Utility Global’s India Steel Move Needs Hard Numbers

Updated Category News Views 104

Steel decarbonization announcements can sound enormous before a single bolt gets tightened. Utility Global says it plans to deploy its first industrial H2Gen project in India with Tata Steel, and that is plainly worth watching. Tata Steel is a serious industrial name, India is a consequential steel market, and any technology that can credibly lower emissions from heavy...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 78

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Innovations in Cannabinoid Medicine at Avicanna's Symposium

Updated Category News Views 131

Avicanna's 5th Medical Symposium on Cannabinoid Medicine On June 6, a well-anticipated medical symposium will be hosted by Avicanna Inc., a prominent biopharmaceutical company dedicated to the innovative exploration of cannabinoid-based medicine. This exciting event, taking place at the MaRS Discovery District, aims to bring together healthcare practitioners and...

Continue Reading
Gordian's Exciting New Initiative for Public Facility Planning

Updated Category News Views 277

Gordian's New Sourcewell Contract Gordian, a well-known provider of data-driven solutions for various phases of the building lifecycle, has recently secured a significant contract with Sourcewell. This partnership will broaden Gordian’s offerings to numerous government and educational organizations eager to enhance their facility planning capabilities. Facilitating...

Continue Reading
Paramount Global CFO Transition: A New Era Begins

Updated Category News Views 251

Paramount Global Announces Significant Leadership Change Paramount Global (NASDAQ: PARA) has made a noteworthy announcement regarding its executive leadership. Naveen Chopra, who has been serving as the Chief Financial Officer and Executive Vice President, will be departing from the company to explore new opportunities. The company's Board of Directors has stated that...

Continue Reading
Explore the Potential of Axsome, CRISPR, and Pfizer Stocks

Updated Category News Views 134

Back in 2023, the stock market was a mixed bag, with plenty of sectors showing serious signs of overvaluation. You had legends like Warren Buffett sitting on a mountain of cash, clearly indicating he saw overpriced stocks everywhere. When seasoned investors hit the brakes on buying due to high valuations, it’s like an alarm bell for everyone else—caution was in the...

Continue Reading
Boeing's Production Delays and Its Impact on Suppliers

Updated Category News Views 245

A Closer Look at Boeing's Production Setbacks Boeing Co has recently notified its suppliers about a significant change to a key production milestone for its 737 MAX aircraft. This adjustment, which extends the timeline by six months, has raised concerns within the aviation industry. Sources indicate that the new objective is to achieve an output of 42 jets per month by...

Continue Reading